Pandemic Demand Forces Rapidly Increased Production And Expertise
Source: Cytiva

To combat COVID-19, the life sciences industry rapidly changed its pace. Solis BioDyne, one of the leading reagent suppliers in Europe, manufactures PCR/qPCR reagents and specifically a ribonuclease inhibitor used for COVID-19 RT-qPCR diagnostic tests. Previously manufactured at bench scale, the company now needed to quickly increase production 50-fold to meet the demand of COVID-19 tests. Solis BioDyne faced two challenges: safely producing this large volume and maintaining a very high quality.
VIEW THE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of BioProcess Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more